[Prospective, monocentric, uncontrolled study of efficacy, tolerance and adherence of cyclosporin 0.1  % for severe dry eye syndrome].

CONCLUSION: Ikervis® is an effective treatment of severe dry eye. Its indications tend to evolve towards less severe dry eye. However, the tolerability profile remains poor, and an improvement in this would be desirable.
PMID: 29449025 [PubMed - as supplied by publisher]

Source: Journal Francais d Ophtalmologie - February 18, 2018 Category: Opthalmology Tags: J Fr Ophtalmol Source Type: research